Eric Steen - InfuSystems Holdings CEO and President and Director
| INFU Stock | USD 7.87 0.14 1.75% |
CEO
Mr. Eric Steen was appointed as President, Chief Executive Officer, Director of Infusystem Holdings, Inc., effective April 1, 2013. Mr. Steen has served as Chief Executive Officer and President of the Company since April 1, 2013. Prior to his service as Chief Executive Officer and President of the Company, Mr. Steen served as the principal of Eric K. Steen Associates, a consulting business providing services to medical device and pharmaceutical companies, from February 2012 to March 2013. Prior to forming Eric K. Steen Associates, Mr. Steen was President of Central Admixture Pharmacy Services, where he turned a startup company into a successful 150 million pharmacy services organization with 25 locations. Mr. Steen was employed at Central Admixture Pharmacy Services from 1992 to 2012, and served as President starting in 1997. Mr. Steen concurrently served as the Chief Marketing Officer of B. Braun Medical Inc., a 1.5 billion organization offering infusion therapy and pain management products and services. Mr. Steen was employed at B. Braun Medical Inc. from 1997 to 2012. Mr. Steen began his career in sales and operations management at American Hospital Supply Corporationration, where he was employed from 1978 to 1983, and at Baxter Healthcare, where he was employed from 1983 to 1992 since 2013.
| Age | 57 |
| Tenure | 11 years |
| Professional Marks | MBA |
| Address | 3851 West Hamlin Road, Rochester Hills, MI, United States, 48309 |
| Phone | 248-291-1210 |
| Web | https://www.infusystem.com |
InfuSystems Holdings Management Efficiency
The company has return on total asset (ROA) of 0.0253 % which means that it generated a profit of $0.0253 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0174 %, meaning that it created $0.0174 on every $100 dollars invested by stockholders. InfuSystems Holdings' management efficiency ratios could be used to measure how well InfuSystems Holdings manages its routine affairs as well as how well it operates its assets and liabilities. At this time, InfuSystems Holdings' Return On Tangible Assets are comparatively stable compared to the past year. Return On Assets is likely to gain to 0.01 in 2024, whereas Return On Capital Employed is likely to drop 0.04 in 2024. At this time, InfuSystems Holdings' Non Current Liabilities Other is comparatively stable compared to the past year. Change To Liabilities is likely to gain to about 3.6 M in 2024, whereas Total Current Liabilities is likely to drop slightly above 15.5 M in 2024.Similar Executives
| Found 9 records | CEO Age | ||
| Kathleen Skarvan | Electromed | 68 | |
| John Richards | The Joint Corp | 65 | |
| Peter Holt | The Joint Corp | 65 | |
| Jan Haverhals | Milestone Scientific | 62 | |
| Gian Trombetta | Milestone Scientific | 54 | |
| Brian Balbirnie | Issuer Direct Corp | 53 | |
| Daniel Goldberger | Milestone Scientific | 57 | |
| David Bruce | IRIDEX | 65 | |
| Leonard Osser | Milestone Scientific | 77 | |
Management Performance
| Return On Equity | 0.0174 | ||||
| Return On Asset | 0.0253 |
InfuSystems Holdings Leadership Team
Elected by the shareholders, the InfuSystems Holdings' board of directors comprises two types of representatives: InfuSystems Holdings inside directors who are chosen from within the company, and outside directors, selected externally and held independent of InfuSystems. The board's role is to monitor InfuSystems Holdings' management team and ensure that shareholders' interests are well served. InfuSystems Holdings' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, InfuSystems Holdings' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Thomas Ruiz, Ex Officer | ||
| Greg Schulte, CFO | ||
| Darrell Montgomery, Director | ||
| Richard Diiorio, President CEO, Director | ||
| Barry Steele, Executive CFO | ||
| Scott Shuda, Director | ||
| Joseph Whitters, Independent Director | ||
| BSN MBA, COO Pres | ||
| Christopher Sansone, Director | ||
| Jonathan Foster, CFO | ||
| David Dreyer, Independent Director | ||
| Wayne Yetter, Independent Director | ||
| Addam Chupa, Executive Officer | ||
| Ryan Morris, Non-Executive Chairman of the Board | ||
| Michael McReynolds, CIO and Executive VP | ||
| Trent Smith, Executive Vice President Chief Accounting Officer, Corporate Controller | ||
| Gregory Schulte, CFO | ||
| Jeanie Latz, Corporate Secretary | ||
| Christopher Downs, Interim CFO, Executive Vice President | ||
| Jerod Funke, Executive Officer | ||
| Janet Skonieczny, COO and Executive VP | ||
| Rob Swadosh, IR Contact | ||
| Eric Steen, CEO and President and Director | ||
| Jeannine Sheehan, Exec Officer | ||
| Gregg Lehman, Director |
InfuSystems Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is InfuSystems Holdings a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0174 | ||||
| Return On Asset | 0.0253 | ||||
| Profit Margin | 0.01 % | ||||
| Operating Margin | 0.04 % | ||||
| Current Valuation | 200.73 M | ||||
| Shares Outstanding | 21.26 M | ||||
| Shares Owned By Insiders | 5.81 % | ||||
| Shares Owned By Institutions | 82.23 % | ||||
| Number Of Shares Shorted | 233.72 K | ||||
| Price To Earning | 10.72 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards InfuSystems Holdings in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, InfuSystems Holdings' short interest history, or implied volatility extrapolated from InfuSystems Holdings options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in InfuSystems Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in census. For more information on how to buy InfuSystems Stock please use our How to Invest in InfuSystems Holdings guide.Note that the InfuSystems Holdings information on this page should be used as a complementary analysis to other InfuSystems Holdings' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Complementary Tools for InfuSystems Stock analysis
When running InfuSystems Holdings' price analysis, check to measure InfuSystems Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InfuSystems Holdings is operating at the current time. Most of InfuSystems Holdings' value examination focuses on studying past and present price action to predict the probability of InfuSystems Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InfuSystems Holdings' price. Additionally, you may evaluate how the addition of InfuSystems Holdings to your portfolios can decrease your overall portfolio volatility.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |
Is InfuSystems Holdings' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of InfuSystems Holdings. If investors know InfuSystems will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about InfuSystems Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.99) | Earnings Share 0.04 | Revenue Per Share 5.983 | Quarterly Revenue Growth 0.101 | Return On Assets 0.0253 |
The market value of InfuSystems Holdings is measured differently than its book value, which is the value of InfuSystems that is recorded on the company's balance sheet. Investors also form their own opinion of InfuSystems Holdings' value that differs from its market value or its book value, called intrinsic value, which is InfuSystems Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because InfuSystems Holdings' market value can be influenced by many factors that don't directly affect InfuSystems Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between InfuSystems Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if InfuSystems Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, InfuSystems Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.